AU2001251414A1 - Method of detecting carcinomas - Google Patents
Method of detecting carcinomasInfo
- Publication number
- AU2001251414A1 AU2001251414A1 AU2001251414A AU5141401A AU2001251414A1 AU 2001251414 A1 AU2001251414 A1 AU 2001251414A1 AU 2001251414 A AU2001251414 A AU 2001251414A AU 5141401 A AU5141401 A AU 5141401A AU 2001251414 A1 AU2001251414 A1 AU 2001251414A1
- Authority
- AU
- Australia
- Prior art keywords
- detecting carcinomas
- carcinomas
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/558,880 US6500633B1 (en) | 2000-04-26 | 2000-04-26 | Method of detecting carcinomas |
US09558880 | 2000-04-26 | ||
PCT/US2001/011317 WO2001081362A1 (en) | 2000-04-26 | 2001-04-06 | Method of detecting carcinomas |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001251414A1 true AU2001251414A1 (en) | 2001-11-07 |
Family
ID=24231363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001251414A Abandoned AU2001251414A1 (en) | 2000-04-26 | 2001-04-06 | Method of detecting carcinomas |
Country Status (3)
Country | Link |
---|---|
US (1) | US6500633B1 (en) |
AU (1) | AU2001251414A1 (en) |
WO (1) | WO2001081362A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8594942B2 (en) * | 2004-07-30 | 2013-11-26 | Metabolon, Inc. | Computational method and system for identifying network patterns in complex biological systems data |
US20080020472A1 (en) * | 2005-11-22 | 2008-01-24 | Frantz Biomarkers, Llc | Method for detecting an inflammatory disease or cancer |
US7491504B2 (en) | 2005-11-22 | 2009-02-17 | Frantz Biomarkers, Llc | Method for detecting ovarian cancer |
US9217749B2 (en) * | 2006-05-31 | 2015-12-22 | Lpath, Inc. | Immune-derived moieties reactive against lysophosphatidic acid |
US8796429B2 (en) * | 2006-05-31 | 2014-08-05 | Lpath, Inc. | Bioactive lipid derivatives, and methods of making and using same |
US9274130B2 (en) | 2006-05-31 | 2016-03-01 | Lpath, Inc. | Prevention and treatment of pain using antibodies to lysophosphatidic acid |
US9274129B2 (en) * | 2006-05-31 | 2016-03-01 | Lpath, Inc. | Methods and reagents for detecting bioactive lipids |
US20080213768A1 (en) * | 2006-08-17 | 2008-09-04 | Zhauhui Cai | Identification and use of biomarkers for non-invasive and early detection of liver injury |
EP2082218A2 (en) * | 2006-10-03 | 2009-07-29 | Oklahoma Medical Research Foundation | Metabolite detection using magnetic resonance |
US20100291690A1 (en) * | 2007-11-07 | 2010-11-18 | Lian Shan | Methods for detecting or monitoring cancer using lpc as a marker |
WO2009061404A1 (en) * | 2007-11-07 | 2009-05-14 | Frantz Biomarkers, Llc | Methods for detecting or monitoring cancer using lpc as a marker |
WO2012103787A1 (en) * | 2011-02-01 | 2012-08-09 | The University Of Hongkong | Use of anti-dkk1 monoclonal antibody for treatment of liver cancer |
EP2686347B1 (en) | 2011-03-16 | 2018-05-02 | argenx BVBA | Antibodies to cd70 |
JO3283B1 (en) | 2011-04-26 | 2018-09-16 | Sanofi Sa | Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri) |
JP5872285B2 (en) * | 2011-12-28 | 2016-03-01 | 株式会社島津製作所 | Renal cancer blood marker |
KR101890885B1 (en) * | 2013-02-15 | 2018-08-22 | 토마스 제퍼슨 유니버시티 | Method for detecting shed or circulating tumor cells in biological fluids |
EA035674B1 (en) | 2014-07-18 | 2020-07-24 | Санофи | Method of determining whether a patient suspected to suffer from cancer is a candidate for aflibercept therapy |
US10391168B1 (en) | 2014-08-22 | 2019-08-27 | University Of Bern | Anti-CD70 combination therapy |
JP6900314B2 (en) * | 2014-12-24 | 2021-07-07 | ジェネンテック, インコーポレイテッド | Treatment, diagnosis, and prognosis of bladder cancer |
WO2017129537A1 (en) * | 2016-01-25 | 2017-08-03 | Sanofi | Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer by measuring the level of a plasma biomarker |
GB201800649D0 (en) | 2018-01-16 | 2018-02-28 | Argenx Bvba | CD70 Combination Therapy |
UY38511A (en) | 2018-12-18 | 2020-07-31 | Argenx Bvba | COMBINATION THERAPY CD70 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55118419A (en) | 1979-03-05 | 1980-09-11 | Toyama Chem Co Ltd | Antihemolytic composition consisting of fat emulsion and immunizator and carcinostatic agent containing the same |
DE3231288C2 (en) * | 1982-08-23 | 1984-06-28 | MEDI-PHARMA Vertriebsgesellschaft mbH, 5000 Köln | Diagnostic device and its use |
JPS59140900A (en) | 1983-01-28 | 1984-08-13 | Toyo Jozo Co Ltd | Novel method for highly sensitive, enzymatic determination |
US4698299A (en) | 1985-02-19 | 1987-10-06 | The Liposome Company, Inc. | Lipid-dependent diagnostic assays |
JPS63233800A (en) | 1987-03-20 | 1988-09-29 | Toyo Jozo Co Ltd | Method for measuring activity of lecithin cholesterol acyltransferase |
JP2872256B2 (en) | 1987-08-27 | 1999-03-17 | イーライ リリー アンド カンパニー | Synovial membrane phospholipase |
FR2623508B1 (en) | 1987-11-20 | 1990-04-20 | Commissariat Energie Atomique | BASIC PROTEIN NAMED PHOSPHOLIPASE A2 ISOLATED FROM SNAP VENOM OF THE ELAPID FAMILY AND ITS AMINO ACID SEQUENCE, DERIVATIVES AND FRAGMENTS OF THE SAME, PROCESS FOR OBTAINING THERAPEUTIC COMPOSITIONS, AND DIAGNOSTIC AGENTS CONTAINING SAME AND / OR ITS FRAGMENTS |
JP2707642B2 (en) | 1988-10-15 | 1998-02-04 | 日本油脂株式会社 | Method for producing lysophospholipid |
JPH04503957A (en) | 1989-03-07 | 1992-07-16 | ジェネンテク,インコーポレイテッド | Covalent conjugates of lipids and oligonucleotides |
JPH07121953B2 (en) | 1991-11-30 | 1995-12-25 | 株式會社眞露 | Novel pyrrolidine derivatives and salts thereof, process for producing the same, medicinal composition and preparation for transdermal administration |
US5489580A (en) | 1992-11-05 | 1996-02-06 | University Of Connecticut | Phospholipid compounds and use therefor |
US5277917A (en) | 1993-04-02 | 1994-01-11 | Allelix Biopharmaceuticals Inc. | Ovarian cancer ascites factor, in isolated form |
JPH0853475A (en) | 1994-08-11 | 1996-02-27 | Daiichi Rajio Isotope Kenkyusho:Kk | Phospholipid compound containing radioactive iodine-labeled boron |
US5824555A (en) * | 1996-05-30 | 1998-10-20 | The Cleveland Clinic Foundation | Method of detecting gynecological carcinomas |
US6248553B1 (en) * | 1998-10-22 | 2001-06-19 | Atairgin Technologies, Inc. | Enzyme method for detecting lysophospholipids and phospholipids and for detecting and correlating conditions associated with altered levels of lysophospholipids |
CA2389832A1 (en) | 1999-11-04 | 2001-05-10 | Abbott Laboratories | Improved automated lpa assay and methods of detecting cancer |
-
2000
- 2000-04-26 US US09/558,880 patent/US6500633B1/en not_active Expired - Lifetime
-
2001
- 2001-04-06 AU AU2001251414A patent/AU2001251414A1/en not_active Abandoned
- 2001-04-06 WO PCT/US2001/011317 patent/WO2001081362A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US6500633B1 (en) | 2002-12-31 |
WO2001081362A1 (en) | 2001-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001251414A1 (en) | Method of detecting carcinomas | |
AU2001276484A1 (en) | Drilling method | |
AU2001240115A1 (en) | Method for the preparation of tetrahydrobenzothiepines | |
AUPQ687600A0 (en) | A method of detection | |
AU2002346008A1 (en) | Method for detection of melanoma | |
AU6364699A (en) | Detection of analytes | |
AU2002210881A1 (en) | Transdermal method | |
AU2001281633A1 (en) | Detection method | |
AU2001268701A1 (en) | Methods of enhancing adhesion | |
AUPR050700A0 (en) | Detection method | |
AUPQ667800A0 (en) | Detection method | |
AU5867901A (en) | Method for detecting tumors | |
AU5650401A (en) | Method for enhancing cognitive function | |
AU2001237530A1 (en) | Method | |
AU2001260716A1 (en) | Method of detecting saccharified albumin | |
AU2002221104A1 (en) | Method of detecting relation between genes | |
AU2001241636A1 (en) | Halotherapy method | |
AU2001246862A1 (en) | Method of detecting cancer | |
AU2002220757A1 (en) | Method for obtaining azaerythromycin | |
AU2001264000A1 (en) | Phosphomagnesium mortar and method for obtaining same | |
AU2001232231A1 (en) | Method for detecting substance | |
AUPQ639300A0 (en) | Method of enhancing or maintaining a relationship | |
AUPQ781100A0 (en) | A method of detection | |
AUPQ677300A0 (en) | Detection method | |
AU2001286268A1 (en) | Method of forming complex |